-
Kenya's economy faces climate change risks: World Bank
-
Italy's spread-out Olympics face transport challenge
-
Paying for a selfie: Rome starts charging for Trevi Fountain
-
Musk merges xAI into SpaceX in bid to build space data centers
-
New York records 13 cold-related deaths since late January
-
In post-Maduro Venezuela, pro- and anti-government workers march for better pay
-
Late-January US snowstorm wasn't historically exceptional: NOAA
-
Punctuality at Germany's crisis-hit railway slumps
-
Europe observatory hails plan to abandon light-polluting Chile project
-
Oil slides, gold loses lustre as Iran threat recedes
-
Russian captain found guilty in fatal North Sea crash
-
Disney earnings boosted by theme parks, as CEO handover nears
-
France demands 1.7 bn euros in payroll taxes from Uber: media report
-
Latest Epstein file dump rocks UK royals, politics
-
More baby milk recalls in France after new toxin rules
-
Germany hit by nationwide public transport strike
-
WHO chief says turmoil creates chance for reset
-
European stocks rise as gold, oil prices tumble
-
Trump says US talking deal with 'highest people' in Cuba
-
Olympic Games in northern Italy have German twist
-
At Grammys, 'ICE out' message loud and clear
-
Steven Spielberg earns coveted EGOT status with Grammy win
-
Kendrick Lamar, Bad Bunny, Lady Gaga triumph at Grammys
-
Japan says rare earth found in sediment retrieved on deep-sea mission
-
Oil tumbles on Iran hopes, precious metals hit by stronger dollar
-
Kendrick Lamar, Bad Bunny, Lady Gaga win early at Grammys
-
Surging euro presents new headache for ECB
-
US talking deal with 'highest people' in Cuba: Trump
-
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades
-
Hans Vestberg, Former Verizon Chairman and CEO, Joins Digipower X As Senior Advisor
-
Nigeria's president pays tribute to Fela Kuti after Grammys Award
-
Iguanas fall from trees in Florida as icy weather bites southern US
-
French IT giant Capgemini to sell US subsidiary after row over ICE links
-
New Epstein accuser claims sexual encounter with ex-prince Andrew: report
-
Snowstorm disrupts travel in southern US as blast of icy weather widens
-
Afghan returnees in Bamiyan struggle despite new homes
-
Mired in economic trouble, Bangladesh pins hopes on election boost
-
Chinese cash in jewellery at automated gold recyclers as prices soar
-
Nvidia boss insists 'huge' investment in OpenAI on track
-
Snowstorm barrels into southern US as blast of icy weather widens
-
Ex-prince Andrew again caught up in Epstein scandal
-
How Lego got swept up in US-Mexico trade frictions
-
Snow storm barrels into southern US as blast of icy weather widens
-
Ex-prince Andrew dogged again by Epstein scandal
-
'Malfunction' cuts power in Ukraine. Here's what we know
-
Women in ties return as feminism faces pushback
-
Ship ahoy! Prague's homeless find safe haven on river boat
-
Epstein offered ex-prince Andrew meeting with Russian woman: files
-
China factory activity loses steam in January
-
Melania Trump's atypical, divisive doc opens in theatres
France to rule on controversial bee-killing pesticide bill
France's top constitutional authority is set on Thursday to rule on the legality of a controversial bill to allow the reintroduction of a pesticide that is harmful to ecosystems but relied on by some European farmers.
The so-called "Duplomb law" has sparked public anger for permitting a return of acetamiprid -- a chemical known to be toxic to pollinators, such as bees, and to the environment.
A student-led petition against the bill garnered more than two million signatures after lawmakers adopted its reintroduction on July 8, when it was rushed through a deeply-divided lower house of parliament without a proper debate.
President Emmanuel Macron has said he is waiting to hear the verdict of the Constitutional Council, which is expected to deliver its ruling on the constitutionality of the law at 6:00 pm (1600 GMT).
If the law is upheld, Macron will have two weeks to enact it or request a second vote in parliament.
Banned in France since 2018, acetamiprid remains legal in the European Union, and proponents say that some French farmers need it to help them compete economically.
The insecticide is particularly sought after by beet and hazelnut growers, who say that they have no alternative against pests and face unfair competition.
But the petition on France's lower-house National Assembly's website, which has garnered more than 2.1 million signatures, calls the measure a "frontal attack on public health".
Beekeepers have described the chemical as "a bee killer", and its effects on humans are also a source of concern, though its risk remains unclear in the absence of large-scale studies.
Left-wing lawmakers, who referred the bill for constitutional review, said it violates France's environmental charter which guarantees the "right to live in a balanced and healthy environment".
For some opponents, frustration stretches beyond environmental and health concerns to exasperation over the country's political deadlock.
One supporter of the petition called it "democratic revenge" after Macron forced a controversial pension reform through parliament in 2023 and dissolved the lower chamber last year, sparking political turmoil that resulted in a hung parliament.
According to a poll published in La Tribune Dimanche in late July, 64 percent of people surveyed hope that Macron will not sign the bill into law but will instead submit it to a new debate in parliament.
In late June, before the law's passage, several thousand demonstrators — including farmers, environmental organisations and scientists -- rallied across France calling for the bill to be withdrawn.
M.Davis--CPN